Bill > HB3082

This bill requires prescription drug manufacturers to provide comprehensive reporting to the Department of Consumer and Business Services about their patient assistance programs, even when drug prices do not increase. Specifically, manufacturers must submit an annual report by March 15th that details the total number of consumers who participated in their patient assistance programs during the previous calendar year. Patient assistance programs are defined as initiatives that help consumers reduce out-of-pocket prescription drug costs through methods like coupons, discount cards, or copayment assistance. The bill expands existing reporting requirements to mandate that manufacturers provide details such as the total value of cost reductions provided, number of refills qualifying for the program, program duration, and eligibility criteria. Additionally, this reporting is now required regardless of whether the prescription drug's price has increased, which represents a significant change from previous regulations. The goal appears to be increasing transparency about how pharmaceutical companies support consumers in managing prescription drug costs, and the information collected will be made available to the public and legislative committees to help understand and potentially address prescription drug affordability.

Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB3082